DIN 02399059 — TEVA-EMTRICITABINE/TENOFOVIR 300 MG; 200 MG
TEVA-EMTRICITABINE/TENOFOVIR is a tablet of Emtricitabine / Tenofovir Disoproxil Fumarate marketed by TEVA CANADA LIMITED. The full Emtricitabine / Tenofovir Disoproxil Fumarate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02399059
- Brand name
- TEVA-EMTRICITABINE/TENOFOVIR
- Active ingredient
- Emtricitabine / Tenofovir Disoproxil Fumarate
- Strength
- 300 MG; 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Nucleoside/nucleotide reverse transcriptase inhibitor combination (antiretroviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Emtricitabine / Tenofovir Disoproxil Fumarate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02496356 | AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE | 200 MG; 300 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02452006 | APO-EMTRICITABINE-TENOFOVIR | 300 MG; 200 MG | TABLET | APOTEX INC | MARKETED |
| 02490684 | AURO-EMTRICITABINE-TENOFOVIR | 300 MG; 200 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02487012 | JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 300 MG; 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02521547 | MINT-EMTRICITABINE/TENOFOVIR | 300 MG; 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02443902 | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300 MG; 200 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02461110 | PMS-EMTRICITABINE-TENOFOVIR | 200 MG; 300 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02274906 | TRUVADA | 300 MG; 200 MG | TABLET | GILEAD SCIENCES CANADA INC | MARKETED |